{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"123.7","value":"856.1"},{"groupId":"OG001","spread":"43.9","value":"3067.0"},{"groupId":"OG002","spread":"31.8","value":"2794.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"5"}],"units":"Participants"}],"title":"AUC (0 to 24); Week1 AM dose;n=3,10,5"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"84.8","value":"981.4"},{"groupId":"OG001","spread":"59.9","value":"3261.1"},{"groupId":"OG002","spread":"36.2","value":"2607.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"5"}],"units":"Participants"}],"title":"AUC (0 to 24); Week1 PM dose;n=4,7,5"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"116.2","value":"1279.0"},{"groupId":"OG001","spread":"92.4","value":"2725.3"},{"groupId":"OG002","spread":"17.8","value":"1184.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"3"}],"units":"Participants"}],"title":"AUC (0 to 24); Week3 AM dose;n=3,7,3"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"102.4","value":"1155.8"},{"groupId":"OG001","spread":"29.2","value":"1662.1"},{"groupId":"OG002","spread":"28.5","value":"1131.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"}],"units":"Participants"}],"title":"AUC (0 to 24); Week3 PM dose;n=3,5,3"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"124.4","value":"860.4"},{"groupId":"OG001","spread":"45.3","value":"3118.3"},{"groupId":"OG002","spread":"32.8","value":"2825.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"5"}],"units":"Participants"}],"title":"AUC (0 to inf); Week1 AM dose;n=3,10,5"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"97.6","value":"932.2"},{"groupId":"OG001","spread":"40.8","value":"2727.2"},{"groupId":"OG002","spread":"28.0","value":"2579.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"5"}],"units":"Participants"}],"title":"AUC (0 to t); Week1 AM dose;n=4,10,5"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"82.5","value":"927.5"},{"groupId":"OG001","spread":"43.4","value":"2840.4"},{"groupId":"OG002","spread":"34.2","value":"2446.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"5"}],"units":"Participants"}],"title":"AUC (0 to t); Week1 PM dose;n=4,9,5"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"110.1","value":"1194.6"},{"groupId":"OG001","spread":"89.8","value":"2472.4"},{"groupId":"OG002","spread":"16.9","value":"1140.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"3"}],"units":"Participants"}],"title":"AUC (0 to t); Week3 AM dose;n=3,7,3"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"96.6","value":"1053.6"},{"groupId":"OG001","spread":"23.3","value":"1490.8"},{"groupId":"OG002","spread":"29.2","value":"1073.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"3"}],"units":"Participants"}],"title":"AUC (0 to t); Week3 PM dose;n=3,6,3"}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"5"}],"units":"Participants"}],"description":"Blood samples were collected at indicated time points post ante-meridiem (AM) and post-meridiem (PM) dose for pharmacokinetic analysis of GSK525762.","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Participants were administered twice daily (BID) oral dose of 20 mg GSK525762.","id":"OG000","title":"Part 1: GSK525762 20 mg BID"},{"description":"Participants were administered twice daily oral dose of 30 mg GSK525762.","id":"OG001","title":"Part 1: GSK525762 30 mg BID"},{"description":"Participants were administered twice daily oral dose of 40 mg GSK525762.","id":"OG002","title":"Part 1: GSK525762 40 mg BID"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"PK Parameter Population. Only those participants with data available at the specified time points were analyzed (indicated by n=X in category titles)","reportingStatus":"POSTED","timeFrame":"pre-dose,0.25,0.5,1,2,4,8,12 hours post-AM dose at Week1Day1 and Week3 Day 4; Week1 Day5(0.5, 3 hours post-AM dose); pre-dose, 0.25,0.5,1,2,4,8,12, 36 hours post-PM dose at Week1Day1 and Week3 Day4","title":"AUC (0 to Inf), AUC (0 to 24) and AUC (0 to t) of GSK525762-Part 1 BID","type":"SECONDARY","unitOfMeasure":"Hours*nanogram per milliter"}